-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
- Cosmetic Ingredient
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Covestro's full-year 2016 adjusted EBITDA rose by 22.
7 percent year-on-year to €2.
0 billion
.
Net income was €795 million, while sales decreased slightly by 1.
5 percent to €11.
9 billion
.
Adjusted EBITDA amounted to EUR 390 million and net income of EUR 124 million in the fourth quarter of 2016, well above the fourth
quarter of 2015 (-EUR 84 million).
Clariant's full-year sales for 2016 totaled CHF 5,847 million, up from CHF
5,807 million in the prior-year quarter.
EBITDA before exceptional items increased by 4 percent
to CHF 887 million.
Net profit was CHF 263 million, up 16 percent
year-on-year.
Sales in the fourth quarter of 2016 amounted to CHF 1,548 million, up by 3 %
in local currency.
EBITDA margin before exceptional items increased to 15.
2 percent
.
For the full year 2017, Clariant expects to increase its EBITDA before exceptional items to 16%~19%, making the return on investment (ROIC) higher than the industry average
.
Huntsman reported fourth-quarter 2016 sales revenue of $2,395 million and net income of $137 million and adjusted EBITDA income of $256 million, compared to sales revenue of $2,332 million and net income of $9 million and adjusted EBITDA income of $240 million
for the same period in 2015.
In 2016, Huntsman had sales revenue of $9.
657 billion and net income of $357 million, compared to full-year 2015 revenue of $10.
299 billion and net profit of $126 million
.